Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Preliminary experience with endoscopic laser surgery for severe twin-twin transfusion syndrome

Article Abstract:

Endoscopic laser coagulation of the placental blood vessels being shared by fetuses suffering from twin-twin transfusion syndrome appears to increase the fetuses' survival rate. In some monozygotic twin pregnancies, an imbalance of blood flow to the fetuses results in the sharing of a blood-source by both fetuses, often resulting in too little blood volume for one twin and too much blood volume in the other. Laser coagulation involves the use of a laser to clot the shared vessels. Previous approaches to treatment have yielded a survival rate for the fetuses of 32%. Forty-five women whose pregnancies were complicated by twin-twin transfusion syndrome, and whose fetuses were at risk as a result, underwent endoscopic laser surgery. The surgery was 100% successful at coagulating the identified blood vessels. Fifty-three percent of the fetuses survived to delivery.

Author: Hecher, Kurt, Ville, Yves, Hyett, Jon, Nicolaides, Kypros
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1995
Complications and side effects, Surgery, Fetofetal transfusion, Multiple birth

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Endoscopy laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome

Article Abstract:

A study was conducted on pregnant women with monochorionic twin pregnancies treated with serial amnioreduction or selective fetoscopic laser coagulation of the communicating vessels on the chorionic plate to compare the efficacy and safety of these two treatments. The results revealed that endoscopic laser coagulation is more effective for severe twin-to-twin transfusion syndrome diagnosed before 26 weeks of gestation.

Author: Ville, Yves, Senat, Marie-Victoire, Deprest, Jan, Michel, Boulvain, Paupe, Alain, Winer, Norbert
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
Science & research, Care and treatment, Research, Comparative analysis, Fetoscopy, Amniocentesis, Pregnancy, Multiple, Multiple pregnancy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


HIV drug resistance

Article Abstract:

The mechanisms underlying the selection of drug-resistant HIV and the consequences of viral resistance are focused. Although viral resistance to new drugs can also develop, the lessons learnt during the process of development may prove helpful in devising new treatment strategies that minimize resistance to the new agents.

Author: Clavel, Francois, Hance, Allan J.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
Influence, HIV antigens

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Evaluation, Therapeutics
Similar abstracts:
  • Abstracts: Histamine-2 receptor antagonists do not alter serum ethanol levels in fed, nonalcoholic men. Do histamine-2 receptor antagonists influence the metabolism of ethanol?
  • Abstracts: Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome
  • Abstracts: Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine
  • Abstracts: The Lancaster experience of 2.0 to 2.5 mg/kg intramuscular ketamine for pediatric sedation: 501 cases and analysis
  • Abstracts: The who, where, and what of rapid sequence intubation: prospective observational study of emergency RSI outside the operating theatre
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.